Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof

Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof

US Patent 6900233 · Granted May 31, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucos2021
Nanopillar field-effect and junction transistors with functionalized gate and ba2018
Nanopillar field-effect and junction transistors with functionalized gate and ba2018
Insulin derivatives having an extremely delayed time-action profile2017
Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicamen2015
Nanopillar field-effect and junction transistors with functionalized gate and ba2015
5-oxoisoxazoles as inhibitors of lipases and phospholipases2015
5-oxoisoxazoles as inhibitors of lipases and phospholipases2015
5-oxoisoxazoles as inhibitors of lipases and phospholipases2015
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases2015
Azole derivatives in the form of lipase and phospholipase inhibitors2014
Azole derivatives in the form of lipase and phospholipase inhibitors2014